Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05562622 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessment of DOT Spectacles in Chinese Children

Study acronym: CATHAY
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints expanded, about 4 wordsv8
  2. Primary completion date: Sep 30, 2025 to Dec 31, 2026
    • Study completion date: Mar 31, 2026 to Dec 31, 2027
    v7
  3. Study completion date: Dec 30, 2025 to Mar 31, 2026v6
  4. Primary completion date: Mar 3, 2024 to Sep 30, 2025
    • Study completion date: Sep 30, 2024 to Dec 30, 2025
    v5
  5. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 200 to confirmed 195
    • Study completion date: Jun 30, 2024 to Sep 30, 2024
    • Site details revised at 5 of 5 sites
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Dec 31, 2023 to Mar 3, 2024
    • Study completion date: Jan 31, 2024 to Jun 30, 2024
    • Start date changed from estimate of Dec 10, 2022 to Feb 5, 2023
    • Site details revised at 5 of 5 sites
  2. Start date: Oct 10, 2022 to Dec 10, 2022v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized, controlled, evaluator-blinded, multicenter, two-arm parallel group clinical trial to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses by comparing to single vision, impact-resistant spectacle lenses in reducing the progression of myopia in children of Chinese origin.
Trial Details
NCT Number NCT05562622
Lead Sponsor SightGlass Vision, Inc.
Conditions
(from sponsor)		 Juvenile Myopia, Myopia
Related terms Myopia
Enrollment 195 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov